Incentives Limit Any Savings in Treating Cancer
New York Times - Jun 12, 2007
In all, cancer doctors billed about $4.4 billion for chemotherapy and anemia medications in 2005, down from $5.6 billion in 2004, with Medicare covering 80 ...
|
|
FDA Approves Genentech's Avastin Colon Cancer Medicine
Pay-Per-View - Los Angeles Times - ProQuest Archiver - Feb 27, 2004
Typically, Medicare and private insurers cover such "off-label" use. TREATMENT: Avastin works with chemotherapy drugs to cut off the blood supply to tumors. ...
|
|
|
|
Medicare Proposes Cuts for Cancer Drugs
WebMD - Jul 27, 2004
Goldsmith says private insurers often follow Medicare's lead on payment issues, meaning that many could cut chemotherapy payments to community doctors. ...
|
|
|
|
MEDICARE ADVANTAGE PLAN AUDITS
$19.95 - Congressional Quarterly - Alacra Store - Oct 16, 2007
The subject of today`s hearing the oversight of private Medicare Advantage plans by the ... If she had learned of her chemotherapy copayments in April, ...
|
|
Chemotherapy Drug Concession
fredericksburg.com - Aug 24, 2004
And yes, some of them are threatening to refuse treating Medicare patients altogether. ... Where does the bulk of a private oncologist's income come from? ...
|
|
Manipulating the system
Ocala - Jun 17, 2007
Medicare requires a 20 percent co-payment by patients on chemotherapy medicines ... Private insurers are slowly reducing their reimbursement levels as well, ...
|
|
